Veradermics, Incorporated (MANE)
Health Care ยท Pharmaceutical Preparations
Veradermics, Incorporated (MANE) is listed on the New York Stock Exchange, where its shares have traded since February 4, 2026. SentiSense covers Veradermics, Incorporated in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Reid Waldman is its chief executive officer. The company reports 21 employees, and its corporate website is www.veradermics.com.
About Veradermics, Incorporated
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Latest reported results
Veradermics, Incorporated reported revenue of $0.00 for Q2 FY2026.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 158 institutions reported holding MANE, with 33.9 million shares worth $4.2 billion in aggregate. The largest reported holders were Suvretta Capital Management, FMR and SR One Capital Management. Of the 5 largest reported holders, 3 added shares and 2 held their positions unchanged during the quarter.
More on MANE
- MANE sentiment: whether news and social coverage of Veradermics, Incorporated leans bullish or bearish, and the stories driving it.
- MANE ownership: all 158 reporting institutions, plus insider and congressional trades.
- MANE financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
SentiSense also tracks daily options readings for Veradermics, Incorporated: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Veradermics, Incorporated do?
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions.
What sector is MANE in?
SentiSense classifies Veradermics, Incorporated in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does MANE stock trade?
Veradermics, Incorporated (MANE) is listed on the New York Stock Exchange, where its shares have traded since February 4, 2026.
Who is the CEO of Veradermics, Incorporated?
Reid Waldman is the chief executive officer of Veradermics, Incorporated.